Setmelanotide for the treatment of severe early-childhood genetic obesity.

Saved in:
Bibliographic Details
Title: Setmelanotide for the treatment of severe early-childhood genetic obesity.
Authors: Roth CL; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, School of Medicine, Seattle WA, USA.
Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2025 Jan; Vol. 13 (1), pp. 3-4. Date of Electronic Publication: 2024 Nov 13.
Publication Type: Journal Article
Journal Info: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39549717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Setmelanotide for the treatment of severe early-childhood genetic obesity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roth+CL%22">Roth CL</searchLink>; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, School of Medicine, Seattle WA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101618821%22">The lancet. Diabetes & endocrinology</searchLink> [Lancet Diabetes Endocrinol] 2025 Jan; Vol. 13 (1), pp. 3-4. <i>Date of Electronic Publication: </i>2024 Nov 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%2C+Diabetes+%26+Endocrinology%22">The Lancet, Diabetes & Endocrinology </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101618821 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-8595 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222138587%22">22138587 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Diabetes Endocrinol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39549717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2213-8587(24)00312-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3
    Titles:
      – TitleFull: Setmelanotide for the treatment of severe early-childhood genetic obesity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roth CL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2213-8595
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The lancet. Diabetes & endocrinology
              Type: main
ResultId 1